Interesting but my focus was on the transfer of “client’s technology” that would reduce the need for this reagent by then by 95%. Any idea who that client is? Is it their competitor or is it a client they were talking about just prior in that section of commentary that has been developing cell based manufacturing technology? Best wishes.